PT3708174T - Métodos e tratamento de trauma - Google Patents

Métodos e tratamento de trauma

Info

Publication number
PT3708174T
PT3708174T PT201732047T PT20173204T PT3708174T PT 3708174 T PT3708174 T PT 3708174T PT 201732047 T PT201732047 T PT 201732047T PT 20173204 T PT20173204 T PT 20173204T PT 3708174 T PT3708174 T PT 3708174T
Authority
PT
Portugal
Prior art keywords
trauma
treatment
methods
Prior art date
Application number
PT201732047T
Other languages
English (en)
Original Assignee
Hemanext Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hemanext Inc filed Critical Hemanext Inc
Publication of PT3708174T publication Critical patent/PT3708174T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Percussion Or Vibration Massage (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
PT201732047T 2017-05-19 2018-05-18 Métodos e tratamento de trauma PT3708174T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762508783P 2017-05-19 2017-05-19

Publications (1)

Publication Number Publication Date
PT3708174T true PT3708174T (pt) 2023-01-16

Family

ID=62528888

Family Applications (2)

Application Number Title Priority Date Filing Date
PT201732047T PT3708174T (pt) 2017-05-19 2018-05-18 Métodos e tratamento de trauma
PT187292883T PT3624812T (pt) 2017-05-19 2018-05-18 Métodos e tratamento de trauma

Family Applications After (1)

Application Number Title Priority Date Filing Date
PT187292883T PT3624812T (pt) 2017-05-19 2018-05-18 Métodos e tratamento de trauma

Country Status (11)

Country Link
US (7) US11026970B2 (pt)
EP (3) EP4112063A1 (pt)
JP (2) JP2020520937A (pt)
CN (1) CN110636850A (pt)
AU (1) AU2018270096A1 (pt)
BR (1) BR112019024249A2 (pt)
CA (1) CA3063445A1 (pt)
ES (2) ES2935691T3 (pt)
MX (1) MX2019013785A (pt)
PT (2) PT3708174T (pt)
WO (1) WO2018213714A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3063445A1 (en) * 2017-05-19 2018-11-22 New Health Sciences, Inc. Methods and treatment of trauma
WO2024064723A1 (en) * 2022-09-20 2024-03-28 Hemanext Inc. Oxygen reduced blood for use in the treatment of traumatic brain injury accompanied by hemorrhagic shock

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6447987B1 (en) 1978-09-09 2002-09-10 The United States Of America As Represented By The Secretary Of The Army Prolonged storage of red blood cells
US4769318A (en) 1986-06-03 1988-09-06 Ube Industries, Ltd. Additive solution for blood preservation and activation
US4880786A (en) 1987-01-14 1989-11-14 Ube Industries, Ltd. Additive solution for blood preservation and activation
US5476764A (en) 1994-09-16 1995-12-19 The Regents Of The University Of California Method using CO for extending the useful shelf-life of refrigerated red blood cells
US5624794A (en) 1995-06-05 1997-04-29 The Regents Of The University Of California Method for extending the useful shelf-life of refrigerated red blood cells by flushing with inert gas
US6162396A (en) 1997-04-26 2000-12-19 The Regents Of The University Of California Blood storage device and method for oxygen removal
US5789151A (en) 1997-05-15 1998-08-04 The Regents Of The University Of California Prolonged cold storage of red blood cells by oxygen removal and additive usage
US6413713B1 (en) 1998-10-30 2002-07-02 Hyperbaric Systems Method for preserving blood platelets
PL2120991T3 (pl) * 2007-02-12 2014-07-31 Biotempt Bv Leczenie urazów krwotocznych krótkimi oligopeptydami
ME02979B (me) * 2009-06-09 2018-10-20 Prolong Pharmaceuticals Llc Kompozicije hemoglobina
US9067004B2 (en) * 2011-03-28 2015-06-30 New Health Sciences, Inc. Method and system for removing oxygen and carbon dioxide during red cell blood processing using an inert carrier gas and manifold assembly
EP2729000B1 (en) * 2011-07-05 2022-12-14 Hemanext Inc. A method for extended storage of red blood cells
CN113694272A (zh) * 2015-03-10 2021-11-26 希玛奈克斯特股份有限公司 氧减少一次性套件、装置及其使用方法
US11013771B2 (en) * 2015-05-18 2021-05-25 Hemanext Inc. Methods for the storage of whole blood, and compositions thereof
US10335538B2 (en) * 2015-12-08 2019-07-02 Priya Visweswaran Balakrishnan System and treatment method to increase circulation and pluripotency of stem and progenitor cells within a patient
BR112018073923A2 (pt) * 2016-05-27 2019-02-26 New Health Sciences, Inc. armazenamento anaeróbico de sangue e método de inativação de patógenos
EP4321215A3 (en) * 2016-06-23 2024-04-17 Hemanext Inc. Methods for managing adverse events in patient populations requiring transfusion
CA3063445A1 (en) * 2017-05-19 2018-11-22 New Health Sciences, Inc. Methods and treatment of trauma

Also Published As

Publication number Publication date
US11576931B2 (en) 2023-02-14
EP3708174A1 (en) 2020-09-16
CN110636850A (zh) 2019-12-31
US11026971B2 (en) 2021-06-08
US20200197438A1 (en) 2020-06-25
MX2019013785A (es) 2020-01-13
EP3624812A1 (en) 2020-03-25
ES2931228T3 (es) 2022-12-27
US20200179446A1 (en) 2020-06-11
EP3624812B1 (en) 2022-08-24
JP2020520937A (ja) 2020-07-16
US20210290669A1 (en) 2021-09-23
US10898517B2 (en) 2021-01-26
US11033581B2 (en) 2021-06-15
US20200376027A1 (en) 2020-12-03
ES2935691T3 (es) 2023-03-09
JP2023063294A (ja) 2023-05-09
CA3063445A1 (en) 2018-11-22
US20200237818A1 (en) 2020-07-30
PT3624812T (pt) 2022-11-30
US11026970B2 (en) 2021-06-08
EP3708174B1 (en) 2022-10-12
US20220118008A9 (en) 2022-04-21
US20230165896A1 (en) 2023-06-01
AU2018270096A1 (en) 2019-11-28
WO2018213714A1 (en) 2018-11-22
BR112019024249A2 (pt) 2020-06-02
US11052110B2 (en) 2021-07-06
EP4112063A1 (en) 2023-01-04
US20210030790A1 (en) 2021-02-04

Similar Documents

Publication Publication Date Title
ZA202006746B (en) Methods of treatment
EP3454945A4 (en) ASH1L INHIBITORS AND METHODS OF TREATMENT THEREOF
EP3256152A4 (en) Treatment of bone fractures and defects
EP3341392A4 (en) COMPOSITIONS AND METHODS FOR TREATING PAIN
EP3706737A4 (en) ASH11 INHIBITORS AND METHOD OF TREATING THEREOF
EP3630175A4 (en) METHODS AND DEVICES FOR THE TREATMENT OF FOOD ALLERGIES
EP3684342C0 (en) TREATMENT PROCEDURES
ZA201907401B (en) Treatment of adipocytes
EP3713583A4 (en) METHODS AND COMPOSITIONS FOR TREATMENT OF THE SKIN
EP3654958A4 (en) METHODS OF PATIENT SELECTION AND TREATMENT OF TRXR OR PRDX OVEREXPRESSING CANCERS
EP3490476A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF SKIN DISORDERS
IL264451B1 (en) A combination of abt-199 and achmetalstat for the treatment of aml
GB201706406D0 (en) Method of treatment
GB201815588D0 (en) Method of treatment
EP3691748A4 (en) ACETAMINOPHEN-PREGABALIN COMBINATIONS AND METHODS OF TREATMENT OF PAIN
GB201511799D0 (en) Composition and methods of treatment
PL3183003T3 (pl) SPOSOBY ZAPOBIEGANIA l/LUB LECZENIA ZAKAŻENIA
EP3599983A4 (en) ENDOSCOPES AND TREATMENT PROCEDURES
GB201621737D0 (en) Compositions and methods of treatment
PT3708174T (pt) Métodos e tratamento de trauma
EP3624722A4 (en) PROCESSES AND DEVICES FOR THE TREATMENT OF SUBCUTANEOUS FAT
GB201605127D0 (en) Composition and methods of treatment
IL271727A (en) Method of treatment and their dosage forms
SG11202005850VA (en) Methods of treatment of hypertrigl yceridemia
GB201503371D0 (en) Methods of screening and treatment